Results presented at the 13th European Respiratory Society Annual Congress in Vienna, Austria, demonstrated that young children whose asthma is triggered by upper respiratory infections experience fewer asthma attacks when treated with Merck & Co’s Singulair (montelukast sodiu…
Business Editors/Health & Pharmaceutical Writers
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Sept. 15, 2003
Merck & Co., Inc. announced today that SINGULAIR(R) (montelukast sodium) is now available by prescription in a new, convenient, once-a-day “oral granules” formulation.
SINGULAIR oral granules (4 mg) can be used once daily in the evening for the prevention and chronic treatment of asthma (Indications and Usage page 9 A) in children a…
The Food and Drug Administration is investigating anecdotal reports that people who use Singulair, the popular asthma and allergy drug, are at greater risk for suicidal thoughts and suicide.
Singulair is a pill prescrib…
Singulair allergy label expands: FDA approves broader allergy indication for Merck’s Singulair for the “relief of symptoms of allergic rhinitis” in pediatric patients July 27. New indication for Singulair (montelukast sodium) i…
Merck & Co. has changed the label of Singulair to include data from a study showing that children taking the drug experienced …
Most Popular
10 Jobs That Pay $30 An Hour
13 Job Interview Mistakes To Avoid
5 Regular Mistakes In Pu…
M2 PRESSWIRE-14 January 2003-Research and Markets: Singulair Sales(C)1994-2003 M2 COMMUNICATIONS LTD RDATE:01132003 Database Table: Singulair Sales Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology and healthcare sectors.
Most Popular
10 Jobs That Pay $30 An H…
Norweco, Inc., has announced the availability of a new Model 96 aerator for use in Singulair[R] Bio-Kinetic[R] wastewater treatment systems.
Related Results
Popular prescription drugs
…
The FDA also approved this month Merck’s Singulair for the relief of symptoms of hay fever in adults and children as young as 2 years of age.
Unlike antihistamines, Singulair treats seasonal allergies by blocking leukotrienes, substances produced by certain cells in the human …
WHITEHOUSE STATION, N.J. — Merck & Co., Inc. today announced changes to the product label for SINGULAIR(R) (montelukast sodium), which includes new information from a 56-week clinical study that demonstrated that child…
Following the FDAs decision to decline approval of their allergic rhinitis, Schering-Plough and Merck & Co. are retracting their NDA. The companies are also ending their respiratory joint venture, resulting in a $105 million payment to Schering-Plough. The company will recognize this fee over the remaining three quarters of this fiscal year.
In May 2000, Schering-Plough and Merck formed this join…
